BiomX
PHGE
7 hedge funds and large institutions have $50M invested in BiomX in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 12 closing their positions.
162% more capital invested
Capital invested by funds: $19.1M → $50M (+$30.9M)
0.01% more ownership
Funds ownership: 0.11% → 0.12% (+0.01%)
46% less funds holding
Funds holding: 13 → 7 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$21M |
| 2 |
RI
RTW Investments
New York
|
+$5.44M |
| 3 |
TWMP
Taylor Wealth Management Partners
Boston,
Massachusetts
|
+$459K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$217K |
| 5 |
CC
Centiva Capital
New York
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$3.35M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$2.67M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.53M |
| 4 |
Walleye Trading
New York
|
-$1.62M |
| 5 |
6CM
683 Capital Management
New York
|
-$1.39M |
PHGE Hedge Fund Activity: Q4 2019 in Review
7 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q4 2019, worth a combined $50M — up 162% from $19.1M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PHGE and 6 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was OrbiMed, opening a new position worth an estimated $21M. The largest seller was K2 Principal Fund, cutting an estimated $3.35M.
- 7 institutional investors held BiomX (PHGE) as of Q4 2019, down from 13 in Q3 2019.
- Funds reported $50M of BiomX stock for Q4 2019, up 162% quarter-over-quarter.
- 6 funds opened new BiomX positions in Q4 2019 and 12 closed out, a net change of -6 holders.
- The largest BiomX buyer in Q4 2019 was OrbiMed, an estimated $21M added.
- The largest BiomX seller in Q4 2019 was K2 Principal Fund, an estimated $3.35M sold.
Based on aggregated 13F filings for Q4 2019.